Molecular Pathology, Diagnostics and Therapeutics of Ovarian Cancers
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 3955
Special Issue Editor
Special Issue Information
Dear Colleagues,
Ovarian cancer is one of the most aggressive malignancies threatening women’s health worldwide. The first-line treatment for advanced ovarian cancer is debulking surgery followed by neoadjuvant chemotherapy. However, most patients would eventually relapse regardless of initial response to the treatment due to chemoresistance and metastasis. Thus, new treatments are urgently needed. This may have a significant impact on the landscape of ovarian cancer treatment and improve overall patient survival.
In this Special Issue, we would like to invite both original research and review articles highlighting recent advances in potential molecular targets, mechanisms of metastasis, chemoresistance and stemness, and immunotherapy therapy (alone or combined with either chemotherapy or targeted therapy) in ovarian cancer.
Prof. Dr. Michelle K.Y. Siu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- targeted therapy
- combination therapy
- immune checkpoint blockade
- small molecule inhibitors
- tumor microenvironment
- metastasis
- treatment resistance
- stemness
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
